CAS Medical Systems, Inc., announced the publication of a clinical study in the Journal of Perinatology utilizing its FORE-SIGHT Absolute Cerebral Oximeter.The study, entitled “Neonatal cerebral oximetry monitoring during ECMO cannulation,” is authored by JC Fenik and K. Rais-Bahrami, both of the Department of Neonatology at Children’s National Medical Center, Washington, DC and the Department of Neonatology at The George Washington University School of Medicine, Washington. The purpose of the study was to monitor changes in cerebral perfusion with FORE-SIGHT cerebral oximetry before, during and after surgery to prepare neonatal patients for extracorporeal membrane oxygenation (ECMO) therapy. The study concludes that 70% of the infants studied do experience cerebral desaturations during cannulation for ECMO and that cerebral oximetry is “a useful bedside tool for management of critically ill neonates.” Andrew E. Kersey, President and Chief Executive Officer stated, “This study is further evidence of the FORE-SIGHT Absolute Cerebral Oximeter’s value and reliability in this critical neonatal clinical setting. The use of FORE-SIGHT is of particular importance before, during and after surgery where traditional pulse oximetry may not be reliable, and previous generation cerebral oximeters provided trend-only information. “In addition to this study, CASMED is expecting publication early this year of various additional clinical research supporting the use and benefits of the FORE-SIGHT Absolute Cerebral Oximeter in both the neonatal and adult arenas. We remain pleased with the growing market interest in FORE-SIGHT. Over the next month, we are exhibiting the FORE-SIGHT monitoring system at two key forums - the 4th International Conference on Brain Monitoring and Neuroprotection in the Newborn and the 25th Annual CNMC Symposium on ECMO & Advanced Therapies for Respiratory Failure.”